Premium Nahrungsergänzungsmittel | artgerecht

Intestinal Mucosal Markers – Meaning & Diagnosis

Intestinal mucosal markers are laboratory values that indicate the condition of the intestinal lining and assist in the diagnosis of bowel disorders.

Regular tips about health Regular tips about health

Things worth knowing about "Intestinal mucosal markers"

Intestinal mucosal markers are laboratory values that indicate the condition of the intestinal lining and assist in the diagnosis of bowel disorders.

What are intestinal mucosal markers?

Intestinal mucosal markers are measurable biological parameters – typically derived from blood or stool samples – that provide information about the condition and functional integrity of the intestinal mucosa (the inner lining of the gut). The intestinal mucosa forms the innermost protective layer of the gastrointestinal tract and plays a critical role in nutrient absorption, immune defense, and acting as a barrier against pathogens and harmful substances.

Damage or dysfunction of the intestinal mucosa can contribute to various conditions, including inflammatory bowel disease, celiac disease, irritable bowel syndrome, and increased intestinal permeability (commonly referred to as „leaky gut syndrome“). Intestinal mucosal markers help detect these changes early and monitor the effectiveness of treatment.

Key intestinal mucosal markers

Zonulin

Zonulin is a protein that regulates the permeability of the intestinal wall. Elevated zonulin levels in blood or stool are considered an indicator of increased intestinal permeability. Raised zonulin has been linked to conditions such as celiac disease, Crohn's disease, and type 1 diabetes.

Alpha-1-antitrypsin (fAATr)

Fecal alpha-1-antitrypsin is a marker for intestinal protein loss. When the mucosal barrier is compromised, this protein leaks into the gut lumen in greater quantities. Elevated levels may indicate protein-losing enteropathy.

Beta-defensin-2

Beta-defensin-2 is an antimicrobial peptide produced by intestinal epithelial cells. It plays an important role in the innate immune defense of the gut. Elevated stool levels may indicate inflammatory activation of the intestinal mucosa, as seen in Crohn's disease or ulcerative colitis.

Calprotectin

Calprotectin is a protein derived from white blood cells (leukocytes) and is measured in stool samples. It is a sensitive marker for intestinal inflammation and is commonly used to monitor the course of inflammatory bowel diseases such as Crohn's disease and ulcerative colitis.

Lactoferrin

Lactoferrin is also a leukocyte-derived protein detectable in stool. It serves as a marker for intestinal inflammation and complements calprotectin in diagnostic evaluations.

Intestinal fatty acid-binding protein (I-FABP)

The intestinal fatty acid-binding protein (I-FABP) is released into the bloodstream when intestinal epithelial cells (enterocytes) are damaged. It is considered an early marker of mucosal injury, for example in cases of intestinal ischemia (reduced blood flow to the bowel) or celiac disease.

Citrulline

Citrulline is an amino acid produced almost exclusively by the epithelial cells of the small intestine. A low blood citrulline level indicates a reduced functional mass of the small intestinal mucosa, which may occur in short bowel syndrome, celiac disease, or after radiation-induced bowel damage.

When are intestinal mucosal markers tested?

Intestinal mucosal markers are used in the following situations:

Suspected inflammatory bowel disease (e.g., Crohn's disease, ulcerative colitis)
Suspected celiac disease or gluten intolerance
Assessment of increased intestinal permeability (leaky gut)
Diagnosis of nutrient malabsorption disorders
Monitoring treatment response in known bowel conditions
Investigation of persistent unexplained gastrointestinal symptoms

Diagnosis and interpretation

The interpretation of intestinal mucosal markers must always be performed in a clinical context, taking into account symptoms, medical history, and other diagnostic findings. Individual markers are rarely definitive on their own and must be evaluated as part of the overall clinical picture. Depending on the marker, measurements can be taken from blood, urine, or stool. Results should be assessed by a physician with experience in gastroenterology.

Treatment for abnormal intestinal mucosal markers

Treatment is directed at the underlying condition:

Celiac disease: Strict gluten-free diet
Inflammatory bowel disease: Medical therapy with aminosalicylates, corticosteroids, immunosuppressants, or biologics
Leaky gut: Dietary modifications, probiotics, and targeted nutrients such as L-glutamine or zinc to support mucosal barrier function
Nutrient deficiencies: Targeted supplementation of deficient nutrients

References

Fasano, A. (2012): Leaky gut and autoimmune diseases. In: Clinical Reviews in Allergy and Immunology, 42(1), 71–78. DOI: 10.1007/s12016-011-8291-x
Tibble, J. A. & Bjarnason, I. (2001): Non-invasive investigation of inflammatory bowel disease. In: World Journal of Gastroenterology, 7(4), 460–465.
Derikx, J. P. et al. (2010): Intestinal fatty acid binding protein: a possible diagnostic marker for gut ischemia in humans. In: Clinica Chimica Acta, 411(13–14), 1012–1014.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category